Table 1 –
Recipient Characteristics
| Clinical and Demographic Data | (n=92) | IRI− (n=46) | IRI+ (n=46) | |
|---|---|---|---|---|
|
| ||||
| RECIPIENT: | ||||
|
| ||||
| Characteristic | Value | Value | Value | P-value* |
| Age, years [mean±SD] | 56±11 | 57±11 | 54±10 | 0.21 |
| Gender [n (%)] | 0.52 | |||
| Female | 36 (39) | 20 (43) | 16 (35) | |
| Male | 56 (61) | 26 (57) | 30 (65) | |
| Race [n (%)] | 0.97 | |||
| Asian | 8 (9) | 4 (9) | 4 (9) | |
| Black/African American | 5 (5) | 3 (7) | 2 (4) | |
| White/Caucasian | 47 (51) | 24 (52) | 23 (50) | |
| Other | 32 (35) | 15 (33) | 17 (37) | |
| Ethnicity [n (%)] | 0.50 | |||
| Hispanic/Latino | 38 (41) | 16 (35) | 22 (48) | |
| Non-Hispanic/Latino | 51 (55) | 28 (61) | 23 (50) | |
| Unknown/Not Reported | 3 (3) | 2 (4) | 1 (2) | |
| Liver Disease Etiology [n (%)] | 0.12 | |||
| alcoholic | 23 (25) | 7 (15) | 16 (35) | |
| HBV | 6 (7) | 3 (7) | 3 (7) | |
| HCV | 33 (36) | 18 (39) | 15 (33) | |
| NAFLD/NASH | 15 (16) | 10 (22) | 5 (11) | |
| AIH | 4 (4) | 2 (4) | 2 (4) | |
| PBC | 2 (2) | 2 (4) | 0 (0) | |
| PSC | 4 (4) | 2 (4) | 2 (4) | |
| ALF | 2 (2) | 2 (4) | 0 (0) | |
| other | 3 (3) | 0 (0) | 3 (7) | |
| HCC [n (%)] | 26 (28) | 16 (35) | 10 (22) | 0.25 |
| MELD, at list [mean±SD] | 26±12 | 25±12 | 28±11 | 0.21 |
| MELD, at transplant [mean±SD] | 36±6 | 36±5 | 36±6 | 0.67 |
| Transplant(s) [n (%)] | 0.39 | |||
| isolated liver | 78 (85) | 41 (89) | 37 (80) | |
| liver-kidney | 14 (15) | 5 (11) | 9 (20) | |
| Split liver [n (%)] | 1 (1) | 1 (2) | 0 (0) | >0.99 |
| LFTs, opening [mean±SD] | ||||
| ALT | 553±559 | 505±466 | 602±559 | 0.37 |
| AST | 1127±1086 | 1040±980 | 1214±1188 | 0.45 |
| Bilirubin | 8.3±6.5 | 6.9±4 | 9.7±8.1 | 0.04* |
| INR | 1.4±0.2 | 1.4±0.2 | 1.5±0.3 | 0.4 |